Taiwan Liposome (NASDAQ:TLC) Cut to Sell at Zacks Investment Research

Zacks Investment Research cut shares of Taiwan Liposome (NASDAQ:TLC) from a hold rating to a sell rating in a research note released on Friday morning, Zacks.com reports. According to Zacks, “Taiwan …
( read original story …)

---